150 related articles for article (PubMed ID: 31043708)
1. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.
Fletcher CE; Sulpice E; Combe S; Shibakawa A; Leach DA; Hamilton MP; Chrysostomou SL; Sharp A; Welti J; Yuan W; Dart DA; Knight E; Ning J; Francis JC; Kounatidou EE; Gaughan L; Swain A; Lupold SE; de Bono JS; McGuire SE; Gidrol X; Bevan CL
Oncogene; 2019 Jul; 38(28):5700-5724. PubMed ID: 31043708
[TBL] [Abstract][Full Text] [Related]
2. Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.
Li Y; Sarkar FH
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):11-7. PubMed ID: 26501150
[TBL] [Abstract][Full Text] [Related]
3. Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer.
Martens-Uzunova ES; Kusuma GD; Crucitta S; Lim HK; Cooper C; Riches JE; Azad A; Ochiya T; Boyle GM; Southey MC; Del Re M; Lim R; Ramm GA; Jenster GW; Soekmadji C
J Extracell Vesicles; 2021 Aug; 10(10):e12136. PubMed ID: 34434533
[TBL] [Abstract][Full Text] [Related]
4. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
[TBL] [Abstract][Full Text] [Related]
5. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
Dahal S; Chaudhary P; Kim JA
Cell Oncol (Dordr); 2023 Aug; 46(4):1113-1126. PubMed ID: 36995683
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.
Zamarbide Losada JN; Sulpice E; Combe S; Almeida GS; Leach DA; Choo J; Protopapa L; Hamilton MP; McGuire S; Gidrol X; Bevan CL; Fletcher CE
J Endocrinol; 2023 Mar; 256(3):. PubMed ID: 36622663
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.
Zhao J; Li Q; Feng B; Wei D; Han Y; Li M; Wang Y; Luo Y; Jiang Y
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698359
[TBL] [Abstract][Full Text] [Related]
8. A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.
Fletcher CE; Deng L; Orafidiya F; Yuan W; Lorentzen MPGS; Cyran OW; Varela-Carver A; Constantin TA; Leach DA; Dobbs FM; Figueiredo I; Gurel B; Parkes E; Bogdan D; Pereira RR; Zhao SG; Neeb A; Issa F; Hester J; Kudo H; Liu Y; Philippou Y; Bristow R; Knudsen K; Bryant RJ; Feng FY; Reed SH; Mills IG; de Bono J; Bevan CL
Mol Cancer; 2022 Mar; 21(1):82. PubMed ID: 35317841
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs are mediators of androgen action in prostate and muscle.
Narayanan R; Jiang J; Gusev Y; Jones A; Kearbey JD; Miller DD; Schmittgen TD; Dalton JT
PLoS One; 2010 Oct; 5(10):e13637. PubMed ID: 21048966
[TBL] [Abstract][Full Text] [Related]
10. ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.
Melekhova A; Baniahmad A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685579
[TBL] [Abstract][Full Text] [Related]
11. Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.
Bernardes JGB; Fernandes MR; Rodrigues JCG; Vinagre LWMS; Pastana LF; Dobbin EAF; Medeiros JAG; Dias Junior LB; Bernardes GM; Bernardes IMM; Santos NPCD; Demachki S; Burbano RMR
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456428
[TBL] [Abstract][Full Text] [Related]
12. Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Beinhoff P; Sabharwal L; Udhane V; Maranto C; LaViolette PS; Jacobsohn KM; Tsai S; Iczkowski KA; Wang L; Hall WA; Dehm SM; Kilari D; Nevalainen MT
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680353
[TBL] [Abstract][Full Text] [Related]
13. Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.
Heninger E; Kosoff D; Rodems TS; Sethakorn N; Singh A; Gungurthi H; Carlson KN; Yang B; Gilsdorf C; Pasch CA; Deming DA; Ellis L; Beebe DJ; Jarrard DF; Lang JM
Med Oncol; 2021 Sep; 38(11):135. PubMed ID: 34581895
[TBL] [Abstract][Full Text] [Related]
14. The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.
Weidle UH; Dickopf S; Hintermair C; Kollmorgen G; Birzele F; Brinkmann U
Cancer Genomics Proteomics; 2018; 15(1):17-39. PubMed ID: 29275360
[TBL] [Abstract][Full Text] [Related]
15. miR-32 promotes MYC-driven prostate cancer.
Scaravilli M; Koivukoski S; Gillen A; Bouazza A; Ruusuvuori P; Visakorpi T; Latonen L
Oncogenesis; 2022 Mar; 11(1):11. PubMed ID: 35228520
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and hyaluronan-mediated motility receptor as new molecular targets of baicalein: new molecular mechanisms for its anticancer properties.
Jiang M; Poudel S; Song K
Arch Pharm Res; 2023 Aug; 46(8):679-693. PubMed ID: 37691050
[TBL] [Abstract][Full Text] [Related]
17. Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors.
Peran I; Vietsch EE; Yan G; Riegel AT; Wellstein A
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326668
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets.
Hussein MA; Munirathinam G
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894390
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.
Verma S; Pandey M; Shukla GC; Singh V; Gupta S
PLoS One; 2019; 14(11):e0224071. PubMed ID: 31756185
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
